The APS have a number of awards recognising excellence
in Pharmaceutical Science

This is a science driven award and is self-nominated by members of the APS. Individuals nominating can come from all sectors where pharmaceutical scientists work, which is reflected in the criteria for eligibility.

This is an award recognising science and experience at international level with emphasis on advocacy and leadership and nominations of deserving individuals are made by APS members.  Nomination can be from all sectors where pharmaceutical scientists work, which is reflected in the criteria for eligibility.

Awarded for substantial services to APS by the board

Recipients of the Academy Medal

Professor Graham Buckton

Dr John Clements

Professor Bill Dawson

Dr Chris Doherty

Dr Tommy Dolan

Dr Eddie French

Mrs Christine Glover

Dr Linda Hakes

Dr Mark McAllister (2020)

Profesor Tony Moffat

Mr Robert Seager

Professor Martin Snowden

Professor Howard Stevens

Dr Richard Storey

Dr Claire Thompson

Profesor Ijeoma Uchegbu

Dr John Wahlich (2018)

Dr Steve Wicks (2019)

Dr David Wyatt

The Academy of Pharmaceutical Sciences is pleased to announce our Call for Nominations for the 2022 APS Award Lecture, to be delivered at APS PharmSci 2022 (7th-9th September 2022) in Belfast.

The award will entail the following for the recipient:

  • To be presented at APS PharmSci 2022 with complimentary registration for the event on the day
  • To deliver a 45 minute lecture within a conference plenary session
  • To be recognized as an award recipient on the APS website

    Nominations

    Nomination should consist of a brief CV and a one page summary of contribution in the following fields:

  • Scientific contribution: Work should be outstanding and ambassadorial in their area with an international reputation
  • Broad scientific awareness and proposed title of your lecture

Nominations must be made by a member of the Academy.

Selection Process

The recipient of the award will be appointed by a Selection Committee comprising of:

  • Representatives of the Academy Board
  • Representatives of the APS PharmSci 2022 Organising Committee

Entries should be submitted via email to info@apsgb.org including ‘PharmSci 2022 Award Leture’ in the subject field. Your email application must include your full name and postal address, a contact telephone number, your email, and your institution or organisation’s name. 

Entries will be judged by an APS panel.

Closing Date for Entries 14th January 2022

Previous winners

PharmSci 2020 Award Lecture
Dr Hans Lennernäs, Uppsala University – ‘Seven successful projects in my research – so far……’

PharmSci 2019 Award Lecture
Prof Clive Roberts, University of Nottingham – ‘The potential of 3D printing in the development and manufacture of medicines and its impact upon Pharmacy’

PharmSci 2017 Award Lecture
Prof Dennis Douroumis University of Greenwich – ‘Some like it hot – an extrusion olution to advance drug deliveries’

PharmSci 2016 Award Lecture
Prof Kay Marshal University of Manchester – ‘Improving World health – What can the Community of Pharmaceutical Scientists Contribute’

The Academy of Pharmaceutical Sciences is pleased to announce our Call for Nominations for the Innovative Science Award Lecture 2022 sponsored by GlaxoSmithKline, to be delivered at APS PharmSci 2022 (7th-9th September 2022) in Belfast.

Entrants are welcome from researchers in pharmaceutical science from across the globe in academia, industry, public service or other scientific establishments. The individual applicant should have demonstrated, through published work, a significant innovation which has the potential for application within the pharmaceutical industry.

Submission Criteria

Applicants are requested to submit their CV and a synopsis of their research of not more than 500 words, focussing on its importance to the pharmaceutical industry and proposed title of your lecture.

Entries should be submitted via email to info@apsgb.org including ‘Innovative Science Award 2022’ in the subject field. Your email application must include your full name and postal address, a contact telephone number, your email, and your institution or organisation’s name. 

Entries will be judged by an APS panel.

Prize

The winner will receive a Commemorative Award, £1,000 in prize money and an invitation to present the Innovative Science Award Lecture on their work at APS PharmSci 2022.

Closing Date for Entries 14th January 2022

Previous winners

APS Innovative Science Award Lecture 2020
Professor Ryan Donnelly, Queen’s University – ‘Poking holes in transdermal delivery limits to provide solutions to global healthcare challenges’

APS Innovative Science Award Lecture 2019
Prof Abdul Basit – ‘Lost in translation’

APS Innovative Science Award Lecture 2017
Prof David Jones  ‘Don’t play what’s there; play what’s not there: Innovating within the Pharmaceutical Sciences’

APS Innovative Science Award Lecture 2016
Prof Ijeoma F. Uchegbu – ‘Differentiated Medicines-Delivery More Than Bioavailability’

The Academy of Pharmaceutical Sciences is pleased to announce our Call for Nominations for the 2022 Emerging Scientist Award Lecture, to be delivered at APS PharmSci 2022 (7th-9th September 2022) in Belfast.

Entrants are welcome from researchers from across the globe in academia, industry, public service or other scientific establishments. Applicants should be no more than 10 years since award of their degeree or PhD, and have an outstanding track record (for this stage of their career) indicative of excellent potential.

Submission Criteria

Both nominations and self-nominations are welcome. Submission should include:

  • A one-page cover letter, highlighting key achievements of the candidate in the field of pharmaceutical science and suitability for the award
  • A detailed CV 
  • Proposed title of your talk

Entries should be submitted via email to info@apsgb.co.uk including ‘Emerging Scientist Award 2022’ in the subject field. Your email application must include your full name and postal address, a contact telephone number, your email, and your institution or organisation’s name.

Closing Date for Entries 14th January 2022

Entries will be judged by an APS panel.

Prize

The winner will receive an invitation to present the Emerging Scientist Award Lecture on their work at PharmSci 2022, Belfast.

Previous Winners

APS Emerging Scientist Award 2020
Dr Luis Bimbo – Inorganic carriers for drug delivery applications’

APS Emerging Scientist Award 2019
Dr Clare Hoskins – Nano-assassins for pancreatic cancer therapy’

Read More About Academy Awards

Archive: Previous Awards

Winner 2020 Award Lecture-Hans Lennernäs, PhD. Professor in biopharmaceutics
Department of pharmaceutical bioscience and technology,Uppsala university
PROFESSOR  LENNERNAS WILL PRESENT THE LECTURE AT PHARMSCI 2021.

His research objectives has been and are to develop novel strategies of tissue drug targeting and delivery that is expected to improve the clinical use and efficacy of drugs in various diseases, such as metabolic and cancer diseases. He has been the Principal Investigator in an extensive collaboration with Food Drug & Administration, USA, University of Michigan, USA, and Medical Product Agency, Sweden during 1992-2000 to develop the novel FDA regulatory guideline named the Biopharmaceutics Classification System. He has established an extensive human pharmacokinetic database with jejunal permeability values for 45 drug compounds that today is widely used in academia and pharmaceutical industry. Prof. Lennernäs has been the chairman for numerous international conferences. He serves as reviewer for several scientific journals in clinical pharmacology and pharmaceutical science with a focus on drug delivery and pharmacokinetics

The APS Award Lecture is sponsored by Astra Zeneca and invites pharmaceutical scientists who are a member of the APS to nominate researchers from across the globe in academia, industry, public service or other scientific establishments.

The individual nominated should have demonstrated, scientific contribution where work should be outstanding and ambassadorial in their area with an international reputation and have a broad scientific awareness

Innovative Science Award Winner 2020-Professor Ryan F. Donnelly, Chair in Pharmaceutical Technology, School of Pharmacy, Queen’s University Belfast.

PROFESSOR DONNELLY WILL PRESENT HIS LECTURE AT PHARMSCI 2021

Professor Ryan Donnelly is a registered pharmacist. He holds the Chair in Pharmaceutical Technology in the School of Pharmacy at Queen’s University Belfast and is Director of the university’s interdisciplinary research programme Materials & Advanced Technologies for Healthcare, comprising 58 academics from Pharmacy, Chemistry & Chemical Engineering, Mechanical & Aerospace Engineering, Biological Sciences, Nursing and Medicine. His personal research is centred on design and physicochemical characterisation of advanced polymeric drug delivery systems for transdermal and intradermal drug delivery, with a strong emphasis on improving patient outcomes. He is currently developing a range of novel microneedle technologies through independent research, but also in collaboration with several major pharma partners. He has obtained substantial Research Council, charity and industrial funding and authored over 400 peer-reviewed publications.

Professor Donnelly is Communications Chair of the Controlled Release Society and Europe/Africa Editor of Drug Delivery & Translational Research. His work has attracted numerous awards, including Evonik’s Resomer Award (2018), the Controlled Release Society’s Young Investigator Award (2016), BBSRC Innovator of the Year and the American Association of Pharmaceutical Scientists Pharmaceutical Research Meritorious Manuscript Award (2013), the GSK Emerging Scientist Award (2012) and the Royal Pharmaceutical Society’s Science Award (2011).

The Academy of Pharmaceutical Sciences present the Innovative Science Award sponsored by GlaxoSmithKline at PharmSci and invite pharmaceutical scientists to submit an application.

Entrants are welcome from researchers from across the globe in academia, industry, public service or other scientific establishments. The individual applicant should have demonstrated, through published work, a significant innovation which has the potential for application within the pharmaceutical industry.

Winner 2020-Dr Luis M BimboChancellor’s Research Fellow & Lecturer in Drug Delivery
Strathclyde Institute of Pharmacy and Biomedical Sciences,
University of Strathclyde

DR BIMBO WILL PRESENT HIS LECTURE AT PHARMSCI 2021

Luis M. Bimbo is a Chancellor’s Research Fellow and Lecturer in Drug Delivery at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, UK, having graduated as a pharmacist from the University of Coimbra, Portugal in 2006, and completed an MRes in Cell Biology from the same university in 2010. He then undertook a PhD in Pharmaceutical Technology at the University of Helsinki, Finland, defending his thesis (with Distinction) in 2012. His PhD Thesis garnered several national and international awards including the 2012 Best Thesis Award from the Viikki Research Group Organization, which comprises all Biosciences except Medicine, and the 2014 International Award for the Most Outstanding Doctoral Thesis in the Pharmaceutical Sciences by the APV.

He is also the recipient of the 2012 Albert Wuokko Award to a Young Researcher from the Finnish Pharmaceutical Society (Finland’s most prestigious pharmaceutical award to a young researcher) and the 2015 Young Researcher Award from the Faculty of Pharmacy, University of Helsinki, Finland. In addition, he was conferred the title of Docent in Pharmaceutical Nanotechnology (equivalent to Adjunct Professor) at the University of Helsinki, Finland. His research group focuses on developing novel engineered materials for advanced drug delivery systems, such as porous silicon and porous polymers, supramolecular hydrogels, and drug nanocrystals, which so far attracted over £420,000 in external funding and resulted in 20 international peer-reviewed original research publications.

The award recognises researchers from across the globe in academia, industry, public service or other scientific establishments with no more than 10 years since award of their PhD, have an outstanding track record (for this stage of their career) indicative of excellent potential.